- Home
- Companies
- north america
- stem cell
Show results for
Refine by
Industries served
- Medical / Health Care
- Monitoring and Testing
- Chemical & Pharmaceuticals
- Air and Climate
- Agriculture
- Environmental
- Health and Safety
- University / Academia / Research
- Government
- Manufacturing, Other
- Food and Beverage
- Water and Wastewater
- Soil and Groundwater
- Energy
- Aerospace & Air Transport
- Waste and Recycling
- Oil, Gas & Refineries
- Defense
- Paint
- Plastics & Resins
- Construction & Construction Materials
- Mining
- Banking & Finance / Insurance / Legal
- Electronics and Computers
- Glassware
- Retail
- Commercial
- Metal
- Printing
Stem Cell Suppliers In North America
181 companies found
based in, CALIFORNIA (USA)
AIVITA Biomedical is a biotechnology company developing personalized vaccines that target COVID-19 and the seed of all cancers using our autologous cell platform. We leverage our unique expertise in stem cell growth and directed, high-purity ...
based inSouth San Francisco, CALIFORNIA (USA)
CareDx: Transforming Transplant Patient Care Through Novel Surveillance Management Solutions. Our understanding of transplant patients and care teams allows us to develop solutions to extend graft life. With two decades of commitment to transplant ...
AlloSeq HCT can help you save time with a simple workflow and powerful analysis software, all while achieving high sensitivity chimerism monitoring. Engraftment monitoring (chimerism) testing evaluates the success of a hematopoietic ...
based inSan Francisco, CALIFORNIA (USA)
Vetherapy is a team of scientists, bioengineers, veterinarians and entrepreneurs on a mission to bring stem cell therapies to treat complex and challenging diseases for pet. Vetherapy stem cell therapies are the result of nearly 2 decades of ...
Eye Drops: stem cells growth factor solution for the eyes that is applied in ...
based inSan Diego, CALIFORNIA (USA)
Brooklyn ImmunoTherapeutics (BTX) is a clinical-stage biopharmaceutical company committed to creating a world where patients and families with high unmet medical needs have access to effective treatments. We are pioneers in using the latest ...
Mesenchymal stem/stromal cells (MSC) have undergone extensive clinical testing for many diseases and have consistently demonstrated safety. In addition, the immunomodulatory properties of MSC have been well ...
based inBedminster, NEW JERSEY (USA)
Jubilant Therapeutics Inc. is a clinical stage precision therapeutics company advancing potent and selective small molecule modulators to address unmet medical needs in oncology and autoimmune diseases. With an advanced discovery engine which ...
Strong scientific and clinical rationale for LSD1/HDAC6 inhibition in haematological and solid ...
based inBrooklyn, NEW YORK (USA)
EpiBone is a revolutionary bone reconstruction company that allows patients to “grow their own bone”. At EpiBone we are on a mission to use groundbreaking research to transform skeletal repair. Our approach is clear: We practice impeccable science ...
based inSan Diego, CALIFORNIA (USA)
Capricor is Developing Transformative Cell and Exosome-based Therapeutics for the Treatment and Prevention of Diseases. Capricor Therapeutics, Inc. (Nasdaq: CAPR) is a clinical-stage biotechnology company focused on the discovery, development, and ...
Our Bold Approach to Product Development. Capricor’s mission is to develop groundbreaking therapies that can make a meaningful impact on patients’ lives. Our translational approach to product development is based on the strong research ...
based inHolliston, MASSACHUSETTS (USA)
American Durafilm® was founded in 1949 and became one of the three original charter members of the DuPont™ Licensed Industrial Applicator program of Teflon® coatings. Since that time American Durafilm® has expanded to include high performance films ...
All of these high-performance films can serve as blood storage bags and are ideal for cryogenic storage (cryogenic bags) of stem cells and cord blood. Lay Flat Bags can be designed and manufactured to any size with ...
based inColumbia City, INDIANA (USA)
Nanovis is a technology-driven company committed to discovering unmet clinical needs, developing innovative and enabling solutions, and validating new technologies for clinical and market acceptance. Founded in 2008 by Brian Emerick and licensed ...
based inShirley, NEW YORK (USA)
Creative Bioarray is a leading customer-centered biotechnology company and a pioneer with the latest technology of cell patterning. Creative Bioarray has an experienced expert team and is committed to providing comprehensive services and customized ...
Human CD34+ Progenitor Cells, a transmembrane glycoprotein expressed on the surface of hematopoietic progenitor cells and small vascular endothelial cells, is considered to be a marker of ...
based inLa Jolla, California, CALIFORNIA (USA)
AAA Biotech’s antibodies are highly validated and can be used in multiple applications such as ELISA, FC, ICC, IF, IHC, IP, WB, etc. We have antibodies available for rare species and in multiple conjugated forms, in addition to an extensive ...
Stem Cell Factor (SCF); N/A; Active Stem Cell Factor (SCF); KITLG; MGF; SF; KL1; Kitl; FPH2; Kit-Ligand; Steel Factor; Mast Cell Growth Factor; Steel factor; ...
based inCranbury, NEW JERSEY (USA)
Advancing an integrated pipeline of genetic therapies that correct the root cause of complex and rare life-threatening childhood disorders. Our mission is to develop first-in-class and best-in-class, curative gene therapies for patients with ...
PKD is a rare, genetic blood disorder. PKD is caused by a defect in the PKLR gene which is responsible for energy production in red blood cells (RBCs). RBCs carry oxygen to the rest of the body. When the PKLR gene has a defect, RBCs are limited in ...
based inMilpitas, CALIFORNIA (USA)
ASC Therapeutics is a fully incorporated biopharmaceutical company focusing on the development of curative therapeutic products that are enabled by our proprietary gene editing platform, TARGATT and other gene editing technologies developed after 12 ...
Stem cells, including inducible pluripotent stem cells, mesenchymal stem cells (MSCs) and other primary pluripotent cells, hold ...
based inSouth San Francisco, CALIFORNIA (USA)
Senti Bio was founded to create a new generation of smarter medicines that outmaneuver complex diseases using novel and unprecedented approaches. Senti Bio designs and optimizes gene circuits, which are created from novel and proprietary ...
based inSouth San Francisco, CALIFORNIA (USA)
Neurona Therapeutics is driven by rigorous scientific discovery and focused on developing breakthrough treatments for neurological disorders. Neurona Therapeutics is a privately-held, clinical-stage biotherapeutics company focused on discovering and ...
Neurona’s lead product candidate, NRTX-1001, comprises human MGE-type inhibitory GABAergic interneurons derived from pluripotent stem cells. NRTX-1001’s first indication is for the treatment of ...
based inSeattle, WASHINGTON (USA)
AVM Biotechnology is developing and advancing AVM0703, a proprietary formulation of concentrated dexamethasone. This formulation permits the very high dosing necessary to activate the release and trigger the production of the body’s supercharged ...
based inCambridge, MASSACHUSETTS (USA)
At BlueRock, our mission is to create authentic cellular medicines to reverse devastating diseases, with the vision of improving the human condition. Until recently, scientists believed that mature adult cells were permanently locked into their ...
based inSan Diego, CALIFORNIA (USA)
Fate Therapeutics (Nasdaq: FATE) is a clinical-stage biopharmaceutical company dedicated to the development of first-in-class cellular immunotherapies for patients with cancer. We believe that better cell therapies start with better cells. To ...
based inEncinitas, CALIFORNIA (USA)
Cell Culture Collective has established itself over two decades as a leader in delivering top-tier products and services tailored for life science applications. Specializing in cell culture, diagnostic processed serum, cholesterol concentrates, and ...
Defined Bioscience's FGF2-G3 is an innovative recombinant growth factor designed to enhance the efficiency of FGF2-dependent cell cultures. This product is a human protein, derived from E. coli, and comes with a His-tagged protein ...
based inCambridge, MASSACHUSETTS (USA)
Seres Therapeutics is a late-clinical stage biotechnology company with a strong development pipeline and rigorous scientific underpinning, working to revolutionize treatment of a wide range of diseases by modulating the function of the human ...
SER-155 is an investigational, oral, rationally designed, fermented microbiome therapeutic designed to reduce the incidence of gastrointestinal infections, bacteremia, and graft versus host disease (GvHD) in immunocompromised patients, including ...
